Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both-Reference-Cited by-同舟云学术

Atovaquone Compared with Dapsone for the Prevention ofPneumocystis cariniiPneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both

Published:1998-12-24 Issue:26 Volume:339 Page:1889-1895
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

El-Sadr Wafaa M.,Murphy Robert L.,Yurik Teresa McCabe,Luskin-Hawk Roberta,Cheung Tony W.,Balfour Henry H.,Eng Robert,Hooton Thomas M.,Kerkering Thomas M.,Schutz Malte,van der Horst Charles,Hafner Richard

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199812243392604

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 2024;HIV Medicine;2024-05

2. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials;Clinical Microbiology and Infection;2024-04

3. Pneumocystis jirovecii pneumonia in people living with HIV: a review;Clinical Microbiology Reviews;2024-03-14

4. Prevention of pneumocystis pneumonia in patients with hematological diseases: Efficacy of low-dose atovaquone;Int. Journal of Clinical Pharmacology and Therapeutics;2023-11-01

5. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update;Annals of the Rheumatic Diseases;2023-03-16